ATR inhibition selectively sensitizes G 1 checkpoint-deficient cells to lethal premature chromatin condensation
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Premature chromatin condensation (PCC) is a hallmark of mammalian cells that begin mitosis before completing DNA replication. This lethal event is prevented by a highly conserved checkpoint involving an unknown, caffeine-sensitive mediator. Here, we have examined the possible involvement of the caffeine-sensitive ATM and ATR protein kinases in this checkpoint. We show that caffeine's ability to inhibit ATR (but not ATM) causes PCC, that ATR (but not ATM) prevents PCC, and that ATR prevents PCC via Chk-1 regulation. Moreover, mimicking cancer cell phenotypes by disrupting normal G 1 checkpoints sensitizes cells to PCC by ATR inhibition plus low-dose DNA damage. Notably, loss of p53 function potently sensitizes cells to PCC caused by ATR inhibition by a small molecule. We present a molecular model for how ATR prevents PCC and suggest that ATR represents an attractive therapeutic target for selectively killing cancer cells by premature chromatin condensation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, chemical or genetic inhibition of cell cycle checkpoint function sensitizes cancer cells to a wide variety of DNA damaging agents, including UV (Nghiem et al., 2001), ionizing radiation (Syljuasen et al., 2004), alkylating agents (Bunch and Eastman, 1996), and topoisomerase inhibitors (Shao et al., 1997).”
From ATR–Chk1 Pathway Inhibition Promotes Apoptosis after UV Treatment in Primary Human Keratinocytes: Potential Basis for the UV Protective Effects of Caffeine (2009) · cites this paper as Nghiem et al., 2001
The cited source says what the claim attributes to it.
In the citing paper
“Prior studies in human cancer cell lines (Nghiem et al., 2001) and mouse skin (Lu et al., 2005b; Lu et al., 2004) have shown that p53 disruption sensitizes cells to inhibition of ATR.”
From ATR–Chk1 Pathway Inhibition Promotes Apoptosis after UV Treatment in Primary Human Keratinocytes: Potential Basis for the UV Protective Effects of Caffeine (2009) · cites this paper as Nghiem et al., 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
A role for ATR in the DNA damage-induced phosphorylation of p53
Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S.-Y., Taya, Y., Prives, C., & Abraham, R. T. (1999) · Genes & Development · doi:10.1101/gad.13.2.152 · Cited by 1,046
(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway
Lim, D.-S., Kim, S.-T., Xu, B., Maser, R. S., Lin, J., Petrini, J. H. J., & Kastan, M. B. (2000) · Nature · doi:10.1038/35007091 · Cited by 786
Weinert, T. A., Kiser, G. L., & Hartwell, L. H. (1994) · Genes & Development · doi:10.1101/gad.8.6.652 · Cited by 746
Cliby, W. A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.159 · Cited by 536
Self-citation
Research works printed but not linked: 3
- J N Sarkaria, E C Busby, R S Tibbetts, P Roos, Y Taya, L M Karnitz, R T Abraham Cancer Res 59, 4375–4382 (1999).
- K J Russell, L W Wiens, G W Demers, D A Galloway, S E Plon, M Groudine Cancer Res 55, 1639–1642 (1995).
- D J Stewart, H Hugenholtz, V DaSilva, B Benoit, M Richard, N Russell, J Maroun, S Verma Semin Oncol 14, 110–115 (1987).
Cited by
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
“Cells that lack p53, which has a role in G1 control, are more susceptible to caffeine than their wild-type counterpart”
BackgroundSensing and repairing DNA double-strand breaks
Jackson, S. P. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.687 · Cited by 1,128
DNA repair dysregulation from cancer driver to therapeutic target
Curtin, N. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3399 · Cited by 1,051
Targeting DNA damage response pathways in cancer
Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N., & Tarsounas, M. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00535-5 · Cited by 836
TopBP1 Activates the ATR-ATRIP Complex
Kumagai, A., Lee, J., Yoo, H. Y., & Dunphy, W. G. (2006) · Cell · doi:10.1016/j.cell.2005.12.041 · Cited by 746
Metadata
- Authors
- Nghiem, P., Park, P. K., Kim, Y.-S., Vaziri, C., & Schreiber, S. L.
- Affiliations
- Boston University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-07-31
- Volume
- 98
- Issue
- 16
- Pages
- 9092-9097
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC55378
- OpenAlex
- W2000303122
- Cited by
- 290
- References
- 27
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 6 · 2022: 4 · 2021: 11 · 2020: 11 · 2019: 11 · 2018: 7 · 2017: 13 · 2016: 12 · 2015: 11 · 2014: 20 · 2013: 15 · 2012: 18
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (5r01gm052067-06)
- National Institute of General Medical Sciences (GM52067)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08-AR0208703)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- ATR kinase, ATM kinase, G1/S checkpoint, Chk1, caffeine, p53 deficiency, DNA replication checkpoint, mitosis initiation, tumor cell killing, small-molecule kinase inhibitors, therapeutic target
- MeSH terms
- Caffeine, Chromatin, DNA Replication, Humans, Transfection, Tumor Cells, Cultured, G1 Phase, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ATR inhibition selectively sensitizes G 1 checkpoint-deficient cells to lethal premature chromatin condensation. https://app.cochat.ai/papers/10.1073/pnas.161281798
- The paper
- Nghiem, P., Park, P. K., Kim, Y.-S., Vaziri, C., & Schreiber, S. L. (2001). ATR inhibition selectively sensitizes G 1 checkpoint-deficient cells to lethal premature chromatin condensation. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.161281798
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.